Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Lander confirmed as Biden’s science adviser and OSTP director; plus Tranquis, Herophilus and Precigen

May 28, 2021 11:57 PM UTC

The U.S. Senate confirmed Eric Lander, the president and founding director of the Broad Institute of MIT and Harvard, as director of the White House Office of Science and Technology Policy (OSTP). President Joe Biden elevated the OSTP director to a cabinet level position. In this role Lander is expected to take a leading role in shaping the administration’s science policy, including establishment of the proposed Advanced Research Projects Agency – Health (ARPA-H). Lander served as co-chair of the President’s Council of Advisors on Science and Technology for President Barack Obama from 2009 to 2017.

Neurodegenerative and aging-related disease company Tranquis Therapeutics Inc. hired Frederic Godderis as COO and Jonas Hannestad as CMO. Godderis was co-founder and CEO at LARRK Bio Inc. and Hannestad was SVP of clinical development at Alkahest Inc...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article